NEWS

News Articles

Georgia Bio Names 2022 Golden Helix Award Winners

April 11, 2022

Clearside Biomedical’s Rafael Andino and The Georgia Institute of Technology’s Krishnendu Roy to be Honored with Top Award ATLANTA, GA (April 11, 2022) – Georgia Bio, the state’s life science trade association, will celebrate its annual Golden Helix Awards on Thursday, May 5th. Georgia Bio is pleased to announce the winners of the 2022 Golden…

Read More

Pfizer to Acquire ReViral for Up to $525M, Expanding RSV Pipeline

April 8, 2022

Pfizer has agreed to acquire ReViral, a developer of antiviral therapeutics targeting respiratory syncytial virus (RSV), for up to $525 million, the companies said today, in a deal designed to meet the unmet need for RSV treatments by adding ReViral’s infectious disease pipeline and R&D capabilities to those of the buyer. Read full article here

Read More

CMS Decision is an Enormous Setback for Alzheimer’s Patients and a Dangerous Infringement on FDA’s Scientific Autonomy

April 8, 2022

Patients will suffer because of this bureaucratic and unnecessary second-guessing of the FDA, says BIO CEO. Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement in response to the Centers for Medicare and Medicaid Services’ (CMS’s) National Coverage Determination (NCD) to restrict coverage for drugs used to treat…

Read More

Morehouse School of Medicine CEO asks ‘what’s possible’ when leading (Podcast)

April 5, 2022

Dr. Valerie Montgomery Rice’s background in research seems to come in handy as an academic healthcare administrator. Instead of testing theories and making discoveries in a laboratory, the president and CEO of Morehouse School of Medicine (MSM) is helping to uncover the potential of her employees. Read the full article and hear the podcast here

Read More

Portal Innovations Expands Venture Development Platform to Atlanta

April 5, 2022

NATIONAL EXPANSION STRATEGY WILL FUEL VENTURE PORTFOLIO GROWTH Atlanta (April 05, 2022) – Portal Innovations today announced the expansion of its premier life sciences-focused venture development engine to Atlanta, Georgia, where it will invest in and provide the critical resources that early-stage companies need to grow and scale. Portal employs a highly differentiated “Crafted Capital”…

Read More

Potential drug for Alzheimer’s disease could block early damage, MCG researcher says

April 1, 2022

Most drugs proposed for Alzheimer’s disease target the gunk that accumulates in the brains of patients but fail to take enough away to make a difference or improve outcomes, said the head of the new Alzheimer’s Therapeutics Discovery program at Medical College of Georgia. It would be better to target a mechanism much earlier in…

Read More